Two randomised phase III, double blind, placebo controlled trials of thalidomide in patients with advanced non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC)

Siow Ming Lee, R.M. Rudd, Penella J. Woll, Christian H. Ottensmeier, L. E. James, NH Gower, SG Spiro, Mark Jitlal, Allan Hackshaw

Journal of Clinical Oncology · 2008 · 12 citations · 0 references

Concepts

Abstract

8045